Glucose deprivation inhibits multiple key gene expression events and effector functions in CD8+ T cells
Open accessThe DOI matches its Crossref record; 32 of the 33 references it cites were found in a registry or an index.
Abstract
We recently reported that differentiation of CD8(+) T cells from the naïve to the effector state involves the upregulation of glucose-dependent metabolism. Glucose deprivation or inhibition of glycolysis by 2-deoxy-D-glucose (2-DG) selectively inhibited production of IFN-gamma but not of IL-2. To determine a more global role of glucose metabolism on effector T-cell function, we performed gene array analysis on CD8(+) effector T cells stimulated in the presence or absence of 2-DG. We observed that expression of only 10% of genes induced by TCR/CD28 signaling was inhibited by 2-DG. Among these were genes for key cytokines, cell cycle molecules, and cytotoxic granule proteins. Consistent with these results, production of IFN-gamma and GM-CSF, cell cycle progression, upregulation of cyclin D2 protein, cytolytic activity, and upregulation of granzyme B protein and also conjugate formation were exquisitely glucose-dependent. In contrast to glucose, oxygen was little utilized by CD8(+) effector T cells, and relative oxygen deprivation did not inhibit these CTL functional properties. Our results indicate a particularly critical role for glucose in regulating specific effector functions of CD8(+) T cells and have implications for the maintenance of the effector phase of cellular immune responses in target tissue microenvironments such as a solid tumor.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Reduction in mTOR activity diminishes IFNγ transcripts in T cells, mitigating Th1 CD4+ T cell differentiation [227, 228, 229].”
From Tumor microenvironment signaling and therapeutics in cancer progression (2023) · cites this paper as [227]
In the citing paper
“Limiting glucose levels leads to cellular competition; this impairs T‐cell function via decreased mTOR signaling.”
From Tumor microenvironment signaling and therapeutics in cancer progression (2023) · cites this paper as [227]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nicoletti, I., Migliorati, G., Pagliacci, M. C., Grignani, F., & Riccardi, C. (1991) · Journal of Immunological Methods · doi:10.1016/0022-1759(91)90198-o · Cited by 4,579 · cited 1×
“To determine which phase of the cell cycle is blocked by 2-DG, we examined the DNA content of stimulated effector cells by PI staining (Nicoletti assay) [6].”
MethodModel-based analysis of oligonucleotide arrays: Expression index computation and outlier detection.
Li, C., & Wong, W. H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.1.31 · Cited by 3,133 · cited 1×
“Subsequent data analysis involved: i) the normalization of array values by dCHIP software [29], ii) the averaging of two independent samples for each experiment, iii) determining relative expression using normalized values in a Microsoft Excel spreadsheet.”
MethodThree-dimensional segregation of supramolecular activation clusters in T cells
Monks, C. R. F., Freiberg, B. A., Kupfer, H., Sciaky, N., & Kupfer, A. (1998) · Nature · doi:10.1038/25764 · Cited by 1,968 · cited 1×
“In addition, the mature synapse in many systems includes central clearing of talin and partitioning of signaling molecules such as PKC-θ in the central supramolecular activation cluster (cSMAC) [5].”
BackgroundAMP-activated protein kinase induces a p53-dependent metabolic checkpoint
Jones, R. G., Plas, D. R., Kubek, S., Buzzai, M., Mu, J., Xu, Y., Birnbaum, M. J., & Thompson, C. B. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.03.027 · Cited by 1,619
The Role of Oxidative Stress in Carcinogenesis
Klaunig, J. E., & Kamendulis, L. M. (2004) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.44.101802.121851 · Cited by 1,533 · cited 1×
“It is well-established that ROS induce DNA damage and can lead to aberrant activation of AP-1 and NF-κB [22].”
BackgroundMolecular and Functional Profiling of Memory CD8 T Cell Differentiation
Kaech, S. M., Hemby, S., Kersh, E., & Ahmed, R. (2002) · Cell · doi:10.1016/s0092-8674(02)01139-x · Cited by 982 · cited 1×
“expression of glycolytic enzyme genes in effector and memory T cells analyzed ex vivo [20].”
BackgroundFuel feeds function: energy metabolism and the T-cell response
Fox, C. J., Hammerman, P. S., & Thompson, C. B. (2005) · Nature Reviews Immunology · doi:10.1038/nri1710 · Cited by 853 · cited 1×
“The role of cell metabolism in T cell responsiveness to TCR/CD28 ligation has recently been reviewed [3].”
BackgroundThe Immunological Synapse of CTL Contains a Secretory Domain and Membrane Bridges
Stinchcombe, J. C., Bossi, G., Booth, S., & Griffiths, G. M. (2001) · Immunity · doi:10.1016/s1074-7613(01)00234-5 · Cited by 814
Localization of the primary metabolic block produced by 2-deoxyglucose
Wick, A. N., Drury, D. R., Nakada, H. I., Wolfe, J. B., Britton, B., & Grabowski, R. (1957) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)64988-9 · Cited by 780 · cited 1×
“5-SHG and 2-DG are both competitive inhibitors of glucose for the glycolytic proteins hexokinase, phosphoglucoisomerase, and phosphoglucomutase [8,9].”
BackgroundRegulation of immune cells by local-tissue oxygen tension: HIF1α and adenosine receptors
Sitkovsky, M., & Lukashev, D. (2005) · Nature Reviews Immunology · doi:10.1038/nri1685 · Cited by 518 · cited 1×
“Hypoxic conditions are known to induce upregulation of HIF-1α, which promotes expression of genes encoding glycolytic enzymes but also has other physiologic targets [17].”
Background
Cited by
Items 301–387 of 387
Immune Cell Metabolism and Immuno-Oncology
Patel, C. H., & Powell, J. D. (2023) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-061421-042605 · Cited by 11
Benito-Lopez, J. J., Marroquin-Muciño, M., Perez-Medina, M., Chavez-Dominguez, R., Aguilar‐Cázares, D., Galicia-Velasco, M., & López-González, J. S. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2022.1101503 · Cited by 7
“Some reports indicate that glucose deprivation allows the glycolytic enzyme GAPDH to bind the 3’UTR region of the IFN-g transcript and promotes the loss of the open chromatin marks H3K9Ac and H3K27Ac in Th1-related genes, preventing their transcription (30, 31).”
BackgroundFlati, I., Nolfi, M. D. V., Dall’Aglio, F., Vecchiotti, D., Verzella, D., Alesse, E., Capece, D., & Zazzeroni, F. (2023) · Genes · doi:10.3390/genes14101953 · Cited by 8
Ghahari, N., Shegefti, S., Alaei, M., Amara, A., Telittchenko, R., Isnard, S., Routy, J., Olagnier, D. P., & van Grevenynghe, J. (2024) · Communications Biology · doi:10.1038/s42003-024-07326-8 · Cited by 8
“…after TCR engagement by viral Ags, both CD4 and CD8 TM increase glucose uptake and perform aerobic glycolysis; a metabolic state that is usually adopted by highly proliferative cells like cancer cells in which, glucose is fermented into lactate rather than be oxidized in mitochondria 5 – 8 .”
Tiersma, J. F., Evers, B., Bakker, B. M., Reijngoud, D., de Bruyn, M., de Jong, S., & Jalving, M. (2024) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2024.102802 · Cited by 8
Lv, M., Qiu, X., Wang, J., Wang, Y., Liu, Q., Zhou, H. Y., Zhang, A., & Wang, X. (2022) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2022.04.041 · Cited by 7
Applying metabolic control strategies to engineered T cell cancer therapies
Fox, A., & Blazeck, J. (2024) · Metabolic Engineering · doi:10.1016/j.ymben.2024.10.009 · Cited by 7
Rukonge, P. A., Kawuribi, V., Sheng, Y., Wei, Q., Kun, Y., Niyodukunda, P., Wang, T., Lu, Z., Miao, Y., Xu, K., et al. (2025) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.105094 · Cited by 9
Sattler, A., Gamradt, S., Pross, V., Thole, L., He, A., Schrezenmeier, E., Jechow, K., Gold, S. M., Lukassen, S., Conrad, C., et al. (2024) · JCI Insight · doi:10.1172/jci.insight.166833 · Cited by 6
“…https://doi.org/10.1172/jci.insight.166833 showing reduced expression over unstimulated controls in spike-activated T cells, which is concomitant with the well-described switch from oxidative metabolism to aerobic glycolysis to support rapid effector function after activation (33, 34).”
InfluentialAehnlich, P., Santiago, M. V., Dam, S. H., Saló, S. F., Rahbech, A., Olsen, L. R., Straten, P. T., Desler, C., & Olofsson, G. H. (2024) · Cytotherapy · doi:10.1016/j.jcyt.2024.04.072 · Cited by 8
Xiao, Y., Pang, N., Ma, S., Gao, M., & Yang, L. (2024) · Nutrients · doi:10.3390/nu16213577 · Cited by 9
“which in turn promote CD8 + T cell exhaustion [9,11,12,34,35].”
BackgroundSanchez, J., Jackson, I., Flaherty, K. R., Muliaditan, T., & Schurich, A. (2020) · Metabolites · doi:10.3390/metabo10110461 · Cited by 7
“Experimentally, pharmacological inhibition of glycolysis by the glucose analogue 2-deoxy-d-glucose (2DG) dramatically affects T cell effector functions, impairs TCR signalling and alters T cell proliferation [18].”
BackgroundGreier, M. D. C., Runge, A., Dudás, J., Hartl, R., Santer, M., Dejaco, D., Steinbichler, T. B., Federspiel, J., Seifarth, C., Konschake, M., et al. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1364577 · Cited by 5
“This leads to competition between T cells and tumor cells for nutrients, especially glucose, and impaired T cell effector functions (15, 16).”
BackgroundMetabolic traits of T cells and the implications in autoimmune diseases
Zhou, Y., Zhou, Y., Zhu, Q., Guo, W., & Li, C. (2026) · Autoimmunity Reviews · doi:10.1016/j.autrev.2026.103989 · Cited by 7
Su, H., Bak, E., Kim, A., Tissera, K., Cha, J., & Jang, S. (2022) · The Journal of Microbiology · doi:10.1007/s12275-022-2130-z · Cited by 6
Majdoubi, A., Lee, J. S., Kishta, O. A., Balood, M., Moulefera, M. A., Ishido, S., Talbot, S., Cheong, C., Alquier, T., & Thibodeau, J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01953 · Cited by 5
“Indeed, T-cell priming requires the switch from oxidative phosphorylation to aerobic glycolysis, and the inhibition of glycolysis facilitates the generation of memory T cells (16, 46, 47).”
BackgroundTargeting metabolic reprogramming to overcome immune tolerance in melanoma immunotherapy
Wang, Q., Shi, L., Shi, D., Tai, N., & Wang, X. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1597770 · Cited by 4
Peng, S., Chen, Q., Chen, Z., Yao, M., Cai, Y., He, D., Cai, Y., Cheng, K., Li, J., Cai, H., et al. (2025) · Pancreatology · doi:10.1016/j.pan.2025.12.012 · Cited by 5
Tissue Immunometabolism in Autoimmunity
Villa, M. (2026) · European Journal of Immunology · doi:10.1002/eji.70139 · Cited by 5
2-DG Regulates Immune Imbalance on the Titanium Surface after Debridement
Liu, X., Deng, S., Xie, J., Xu, C., Huang, Z., Huang, B., Chen, Z., & Chen, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411431 · Cited by 3
“5 mM and 1 mM, have been found to have no significant effect on lymphocyte proliferation and, interestingly, can even inhibit the differentiation of T cells into Th17 cells, which are known to contribute to inflammatory responses [46,47].”
BackgroundThe Nuclear Receptor NR1B1/RARα Arrests the Differentiation of Anti‐Tumor Effector Cytotoxic T Cells
Niekamp, P., Kim, R. H., Jayaraman, A., Klement, N., Kostlan, R. J., & Kim, C. H. (2025) · Advanced Science · doi:10.1002/advs.202410241 · Cited by 5
Kang, T., Usherwood, Y.-K., Reisz, J. A., Kamerkar, S. C., Culp‐Hill, R., Wilkins, O. M., Veríssimo, A. F., Kolling, F., Hung, A. M., Musial, S. C., et al. (2025) · JCI Insight · doi:10.1172/jci.insight.187680 · Cited by 4
Electron transport chain capacity expands yellow fever vaccine immunogenicity
Mok, D. Z. L., Tng, D. J., Yee, J. X., Chew, V. S. Y., Tham, C. Y. L., Ooi, J. S. G., Tan, H. C., Zhang, S. L.-X., Lin, L. Z., Ng, W. C., et al. (2024) · EMBO Molecular Medicine · doi:10.1038/s44321-024-00065-7 · Cited by 2
“Furthermore, both glucose deprivation and inhibition of glycolysis have been shown to impair IFN γ production in both activated CD4 + and CD8 + T cells, in vitro (Cham et al, 2008; Chang et al, 2013).”
BackgroundAssessing the Impact of the Nutrient Microenvironment on the Metabolism of Effector CD8+ T Cells
Fernández-García, J., & Fendt, S. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8769-6_14 · Cited by 3
Obstacles in the Development of Therapeutic Cancer Vaccines
Keshavarz‐Fathi, M., & Rezaei, N. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-814039-0.00012-6 · Cited by 3
Ghalamkari, S., Nasiri, M., Ariannia, S., & Farrokhseresht, R. (2017) · Rheumatology Research · doi:10.22631/rr.2017.69997.1033 · Cited by 3
“Evidence indicated that GPR65 may have a role in activation-induced differentiation or T cell death [19].”
BackgroundImmunometabolism in cancer: A journey into innate and adaptive cells
Sant’Ana, A. N., Dias, C. K., Silva, S. K. E., & Figueiró, F. (2024) · International Reviews of Immunology · doi:10.1080/08830185.2024.2401353 · Cited by 2
“In this context, aerobic glycolysis, also known as the Warburg effect, a phenomenon already associated with the metabolism of malignant cells, is the main metabolic program adopted by T lymphocytes after their activation [6, 46].”
Kunitskaya, A., & Piret, J. M. (2025) · Cytotherapy · doi:10.1016/j.jcyt.2025.01.002 · Cited by 2
Dietary iron deficiency impairs effector function of memory T cells following influenza infection
Bradley, M. C., Aliyu, T., Gray, J. I., Guan, T., Carpia, F. L., Idzikowski, E., Jensen, I. J., Bandyopadhyay, S., Guyer, R. S., Pethe, K., et al. (2025) · The Journal of Immunology · doi:10.1093/jimmun/vkaf291 · Cited by 4
Mitochondrial complex II orchestrates divergent effects in CD4+ and CD8+ T cells
Seike, K., Chu, A., Sumii, Y., Ikeda, T., Wu, M.-C., Maneix, L., Zhao, D., Sun, Y., Cieslik, M. P., & Reddy, P. R. (2025) · Journal of Clinical Investigation · doi:10.1172/jci194134 · Cited by 2
“These findings align with prior reports demonstrating that glycolysis fuels the cytolytic capacity of effector CD8 + T cells (29, 30).”
Metabolism of tumor infiltrating T cells
Ertl, H. C. J. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1711328 · Cited by 3
“As was shown in vitro and in vivo , lack of glucose impairs T cell functions by reducing production of effector molecules such as interferon-(IFN)- g , tumor necrosis factor (TNF)- a and granzyme B (14, 62).”
InfluentialSpatiotemporal regulation of energetic charge dictates T cell function
Chikina, A. S., Corre, B., Lemaı̂tre, F., & Bousso, P. (2026) · Nature Communications · doi:10.1038/s41467-026-68559-1 · Cited by 2
Macronutrient availability and immune cell responses
Estevão, P., Martins, A. J. E., & Moraes-Vieira, P. M. (2026) · Seminars in Immunology · doi:10.1016/j.smim.2026.102027 · Cited by 4
Liu, K., Pham, V. T., Fu, S., Sun, L., & Huang, G. (2026) · Hematological Oncology · doi:10.1002/hon.70209 · Cited by 2
“Aggressive metabolic competition creates a nutrient‐deficient environment that restricts effector T cell function, as differentiation of CD8 + T cells from naïve to effector state relies on upregulation of glucose‐dependent metabolism [92, 93].”
Blockade of TIGAR prevents CD8+ T cell dysfunction and elicits anti-AML immunity
Cui, J., Liu, W., Zhong, S., Fang, Y., Pei, X., Xu, C., Wang, R., Hu, X., Zhou, W., Li, K., et al. (2025) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-025-04042-y · Cited by 2
“Glucose deprivation impairs downstream TCR signaling, proliferation, and cytokine production, resulting in an exhausted-like state [41, 42].”
Immunometabolism and Its Potential to Improve the Current Limitations of Immunotherapy
Sheppard, A. D., & Lysaght, J. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-0802-9_17 · Cited by 3
Ketolysis is a metabolic driver of CD8 + T cell effector function through histone acetylationPreprint
Luda, K. M., Kitchen-Goosen, S. M., Ma, E. H., Watson, M. J., Duimstra, L. R., Oswald, B. M., Longo, J., Fu, Z., Madaj, Z., Kupai, A., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.08.26.505402 · Cited by 2
Godfrey, W. H., Lee, J. J., Shanmukha, S., Cho, K., Deng, X., Ambati, C. R., Putluri, V., Kamal, A. H. M., Kim, P. M., Putluri, N., et al. (2025) · eLife · doi:10.7554/elife.104423.3 · Cited by 3
Zheng, R., Zhao, Y., Gong, L., Wang, Y., Xu, K., & Gao, Y. (2026) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2026.178611 · Cited by 2
A Comprehensive Review on the Immune System and Immune Therapy in Liver Cancer and Colorectal Cancer
Alam, F., Ghosh, A., Sen, A., Dey, D., Ghora, S. S., Guchhait, S., Pandey, P., Dutta, A., & Chakraborty, P. (2026) · Biomedical & Pharmacology Journal · doi:10.13005/bpj/3339 · Cited by 1
Mitochondrial Energy Metabolism in Cancer, Immunoregulation and Antitumour Response
Patrício, J. S., Mendes, C., & Gameiro, P. A. (2026) · Advances in experimental medicine and biology · doi:10.1007/978-3-032-12166-0_17 · Cited by 1
Immunotherapy in cancer: Mechanisms and strategies to overcome resistance
Yang, H., Yang, Z., Wang, X., Patel, H. H., Wu, Z., Ashby, C. R., Wang, W., & Chen, Z. (2026) · Drug Resistance Updates · doi:10.1016/j.drup.2026.101447 · Cited by 1
Dynamic Metabolism in Immune Response.
Al-Hommrani, M., Chakraborty, P., Chatterjee, S., & Mehrotra, S. (2016) · PubMed · Cited by 2
Luan, W., & Qi, F. (2022) · Medical Hypotheses · doi:10.1016/j.mehy.2022.110841 · Cited by 2
[Advances in Research on Cell Metabolic Interactions in the Tumor Microenvironment].
Wu, P., Yang, Z., Li, Q., & Wang, D. (2024) · PubMed Central · doi:10.12182/20240360606 · Cited by 4
Parker, G. A. (2017) · Molecular and integrative toxicology · doi:10.1007/978-3-319-47377-2_2 · Cited by 8
“Activated CTLS are highly glycolytic, and reduction in glucose availability results in reduced ability to produce granzymes A & B, perforin and interferon-γ (Cham et al. 2008).”
BackgroundTumor-Induced Metabolism and T Cells Located in Tumor Environment
Iranparast, S., Tayebi, S., Ahmadpour, F., & Yousefi, B. (2020) · Current Cancer Drug Targets · doi:10.2174/1568009620666200720010647 · Cited by 1
Harnessing metabolism for reinvigorating dysfunctional T cells in cancer
Romero‐Garcia, S., Castro‐Flores, D. A., & Prado-García, H. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822028-3.00005-4 · Cited by 2
Matias, M. I., Yong, C. S. M., Foroushani, A. B. K., Sezgin, E., Levental, K. R., Talebi, A., Mongellaz, C., Dehair, J., Wong, M., Kinet, S., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.08.24.256560 · Cited by 1
“Moreover, limiting nutrient resources negatively impacts Teff function (Cham et al., 2008; Chang et al., 2013; Klysz et al., 2015; Macintyre et al., 2014; Metzler et al., 2016; Nakaya et al., 2014) while conversely, increasing glycolysis results in enhanced effector function, monitored as a…”
BackgroundGodfrey, W. H., Lee, J. J., Shanmukha, S., Cho, K., Deng, X., Ambati, C. R., Putluri, V., Kamal, A. H. M., Kim, P. M., Putluri, N., et al. (2025) · eLife · doi:10.7554/elife.104423 · Cited by 1
“…functions of inflammatory T cell subsets, including effector CD8 cells and T-helper (Th) 1 and Th17 CD4 cells ( Frau-wirth et al., 2002 ; Cham and Gajewski, 2005 ; Cham et al., 2008 ; Wang et al., 2011 ; Chang et al., 2013 ; Macintyre et al., 2014 ; Gerriets et al., 2015 ; Shi et al., 2011 ).”
Autophagy disruption primes CAR-T cell metabolism for sustained rejection of ovarian tumorsPreprint
Carleton, G. A., Levesque, S., Zacharias, L. G., Patrício, J. S., Sutcliffe, T., Watson, P. H., DeBerardinis, R. J., Doyon, Y., & Lum, J. J. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.09.681473 · Cited by 1
“Given previous evidence linking glucose uptake with effector function (38,45), we measured intracellular cytokine production and observed markedly elevated IFN-γ expression in both CD4+ and CD8+ ATG5 -knockout CAR-T cells (Figure 4B).”
Gubser, P. M. (2013) · edoc (University of Basel) · doi:10.5451/unibas-006161384 · Cited by 1
“Interestingly, IFN-γ synthesis of effector CD8+ T-cells is intimately linked to glucose metabolism (Cham et al., 2008; Cham and Gajewski, 2005a).”
BackgroundBingham, E. J. (2010) · University Library - University of Saskatchewan (University of Saskatchewan)
Activation To Link Nutrition and Immunity Leptin Metabolically Licenses T Cells for
Rathmell, C., MacIver, N. J., Saucillo, D. C., Gerriets, V. A., & Sheng, J. (2014)
Die immunsuppressive Wirkung von Tumormetaboliten auf humane T-Zellen
Fakultät, N. (2010)
Bergerhoff, K. F. (2016) · UCL Discovery (University College London)
The Secrets of T Cell Polarization
Vargas, T. R., & Apétoh, L. (2017) · Springer eBooks · doi:10.1007/978-3-319-62431-0_5 · Cited by 1
In vivo metabolite tracing of T cellsPreprint
Sheldon, R. D., Ma, E. H., DeCamp, L. M., Williams, K. S., & Jones, R. G. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.08.21.261503
Friedrichs, V., Balkema‐Buschmann, A., Dorhoi, A., & Pei, G. (2021) · Research Square · doi:10.21203/rs.3.rs-604945/v1
Immune Cell Metabolism and Function
Dixit, A. K., & Singh, M. P. (2022) · Springer eBooks · doi:10.1007/978-981-16-6226-3_1
Targeting the Immuno-Oncology Metabolism in Cancer
Tripathi, S. C., Fahrmann, J. F., & Amle, D. B. (2022) · Springer eBooks · doi:10.1007/978-981-16-6226-3_5
T-Cell Metabolism and Its Regulation by Checkpoint Molecules: Consequences for Cancer Immunotherapy
Romero‐Garcia, S., Mendoza, M. S., Carlos‐Reyes, Á., & Prado-García, H. (2023) · Springer eBooks · doi:10.1007/978-3-030-80962-1_159-1
Investigating the Intrinsic Role of Programmed Death-Ligand 1 in Human Cancers.
Hudson, K. (2023) · Sheffield Hallam University · doi:10.7190/shu-thesis-00520
Sarkar, A., Dhar, S., Bera, S., Chakravarti, M., Verma, A., Khan, M. A., Prasad, P., Das, J., Choudhury, P. R., Sultana, J., et al. (2026) · The Journal of Immunology · doi:10.1101/2024.04.04.588206
Enhancing tumor-infiltrating T cells with an exclusive fuel sourcePreprint
Miller, M. L., Thauland, T. J., Nagarajan, R., Zuo, W. E., Lastre, M. A. M., & Butte, M. J. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.05.20.595053
Modulating T cell metabolism to improve T cell therapy
Li, Y., Hung, S.-H., Singh, S., & Yee, C. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13827-0.00008-1
Godfrey, W. H., Cho, K., Deng, X., Ambati, C. R., Putluri, V., Kamal, A. H. M., Putluri, N., & Kornberg, M. D. (2025) · eLife · doi:10.7554/elife.104423.1
Madrigal-Avilés, A., Plajer, V., Mendonca, P. R. V., Serve, S., Soriano‐Baguet, L., Brenner, D., Dzamukova, M. R., Mashreghi, M., & Löhning, M. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.03.647060
Sun, T., Du, J., Lei, Y. L., Guo, J., Zheng, C., & Wang, D. (2025) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-025-00736-8 · Cited by 1
Godfrey, W. H., Lee, J. J., Shanmukha, S., Cho, K., Deng, X., Ambati, C. R., Putluri, V., Kamal, A. H. M., Kim, P. M., Putluri, N., et al. (2025) · eLife · doi:10.7554/elife.104423.2 · Cited by 1
T-Cell Metabolism and Its Regulation by Checkpoint Molecules: Consequences for Cancer Immunotherapy
Romero‐Garcia, S., Mendoza, M. S., Carlos‐Reyes, Á., & Prado-García, H. (2025) · Springer eBooks · doi:10.1007/978-3-032-00765-0_159
Gibson, J. T., Hornburg, M., Lehar, S. M., Javinal, V., Liao, L., McCarron, M. J., Jones, T. N., Oei, Y. A., Dunlap, D. Y., Marroquin, K. A., et al. (2025) · SSRN Electronic Journal · doi:10.1101/2025.11.16.687774
Li, X., & Min, R. (2026) · PLoS ONE · doi:10.1371/journal.pone.0344452
“In CD8 ⁺ T cells, lipid overload is associated with the upregulation of PD-1 and CTLA-4 alongside the downregulation of cytotoxic markers such as GZMB and IFN-γ , where oxidative stress further exacerbates functional decline [58–61].”
Metabolic Constraints and Interactions Drive T-cell Function and Exhaustion in Cancer Progression
Tzeng, S., & Tsai, C.-H. (2026) · Journal of Medical Sciences · doi:10.4103/jmedsci.jmedsci_234_25
Targeting the metabolic environment to modulate T cell effector function
Matias, M. I. (2019) · theses.fr (ABES) · doi:10.70675/0582ddaaze61dz4707z9cb1zdb8fe1d82653
Implication de la GTPase RagA dans l’activation et la polarisation de la réponse lymphocytaire T
Attia, M. (2017) · theses.fr (ABES) · doi:10.70675/54b64a32zdbe2z447dzaab4z42858c3a25e6
Impact du ciblage du domaine de liaison de HIF-1α avec HIF-1β sur le paysage immunitaire du mélanome
Lequeux, A. (2020) · theses.fr (ABES) · doi:10.70675/a29d12dbz79c1z4d37za978z2e2319131c82
The anti-tumoral effects of a low protein diet and of the IRE1α signaling
Turtos, A. M. (2022) · theses.fr (ABES) · doi:10.70675/fd90a3e8ze35az42fdzbd0ez966f12ddad22
Impact of metabolic reprogramming on the immune response in hepatocellular carcinoma
Wang, Y., Lu, Y.-J., Zhou, J., & Yang, X.-R. (2026) · Hepatoma Research · doi:10.20517/2394-5079.2025.105
Citrate Compartmentalization Controls Calcium-Dependent Cytokine Production in Effector T CellsPreprint
Cote, A. L., McIntyre, C., Acklin, J. A., Delacruz, L. R., Qiu, Y., Kurland, I. J., & Ringel, A. E. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.11.731694
Weber, J. L., Bui, T., Nuon, K., Fike, A. J., Crocker, S. M., Bricker, K. N., Maharjan, A., Zhang, W., Goldman, A. R., Chodisetti, S. B., et al. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117587
Coupling and uncoupling cell cycle and metabolism in CD8+ T cells
van Haften, F. J., Hepp, H. S., Biemond, M., & Arens, R. (2026) · Trends in Immunology · doi:10.1016/j.it.2026.09.001
Context-dependent regulation of cytotoxic T lymphocytes by nuclear receptors
Kim, C. H. (2026) · The Journal of Immunology · doi:10.1093/jimmun/vkag261
Zaongo, S. D., & Bado, I. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.119978
Tang, L., 周浩玲, & Liu, J. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1962178
Park, D., Ju, Y.-J., Pyung, Y. J., Kim, C. G., Kim, N., Lim, M., Seo, H., Han, S. H., Cho, J.-H., & Yun, C. (2026) · Science Advances · doi:10.1126/sciadv.aeg0361
“Nutrient utilization, specifically glucose, is a critical energy source for CD8 + T cells, influencing their critical immune functions and T cell differentiation decisions ( 38 ).”
Metadata
- Authors
- Cham, C. M., Driessens, G., O'Keefe, J. P., & Gajewski, T. F.
- Affiliations
- University of Chicago (US)
- Corresponding author
- Gajewski, Thomas F.
- Venue
- European Journal of Immunology
- Publisher
- Wiley
- Published
- 2008-09
- Volume
- 38
- Issue
- 9
- Pages
- 2438-2450
- ISSN
- 0014-2980 (ISSN-L)
- 1521-4141
- PMC
- PMC3008428
- OpenAlex
- W2156145814
- Cited by
- 388
- References
- 33
- Citations by year
- 2026: 21 · 2025: 28 · 2024: 34 · 2023: 42 · 2022: 34 · 2021: 35 · 2020: 42 · 2019: 24 · 2018: 22 · 2017: 29 · 2016: 21 · 2015: 15 · 2014: 10 · 2013: 8 · 2012: 10
- FWCI
- 1.82
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- European Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
- Funders
- National Institute of Allergy and Infectious Diseases (R01 AI47919, R01AI047919)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- glucose deprivation, CD8+ T cells, effector T cells, glycolysis, 2-deoxyglucose, glucose metabolism, interferon-gamma, GM-CSF, granzyme B, cytotoxicity, gene expression, cell cycle progression, cyclin D2, oxygen deprivation, solid tumors, cell-mediated immunity
- MeSH terms
- Animals, Cytotoxicity, Immunologic, Deoxyglucose, Glucose, Lymphocyte Activation, Oxygen, Gene Expression, Cytokines, CD8-Positive T-Lymphocytes, Gene Expression Profiling, Cell Proliferation, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.